Benzinga's Top Pre-Market Losers

Depomed Inc DEPO lost 24.36% to $4.75 in the pre-market session. DEPO reported that the drug did not meet all the goals set in a Phase 3 clinical trial. UBS AG UBS long fell 2.12% to $12.01 in the pre-market trading. Fitch Ratings downgraded UBS' long-term issuer default rating. Microchip Technology Incorporated MCHP moved down 1.90% to $34.64 in the pre-market session. MCHP lowered Q2 forecast. Duke Energy Corporation DUK dipped 1.26% to $19.55 in the pre-market session. DUK's PEG ratio is 3.98.